Metabolic disorders, including obesity, type 2 diabetes mellitus, metabolic syndrome, dyslipidemia, and hypertension, remain among the most pressing global ...
FDA and Capricor aligned on endpoints for HOPE-3 pivotal trial; HOPE-3 pivotal trial completed; topline data expected mid-Q4 2025 to support BLA resubmission; Company preparing to ...
In the area of energy applications, precisely controlling the nanoscale composition, defects, and interfaces in materials has enabled breakthroughs in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback